Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Case Report A Case of Rifampin-induced Severe Thrombocytopenia and Leukopenia in a Patient with Intestinal Tuberculosis
Ji Woong Kim, Gum Mo Jung, Eun Young Cho, Chang Soo Choi, Geom Seog Seo, Jin Woong Cho, Suck Chei Choi, Yong Ho Nah
Intestinal Research 2006;4(1):64-68. Published online: June 30, 2006
Department of Internal Medicine, Wonkwang University College of Medicine, Iksan, Department of Internal Medicine, Presbterian Medical Center, Jeonju, Korea
prev next
  • 1,766 Views
  • 34 Download
  • 0 Crossref
  • 0 Scopus
prev next

Drug induced thrombocytopenia is a relatively not uncommon and potentially serious side effect of therapy. It's characterized by thrombocytopenia, petechia, purpuric lesions and occasionally serious bleeding such as intracranial hemorrhage. The patient was 24 year-old female who was given rifampin 600mg daily for treatment of intestinal tuberculosis. Rifampin-induced immune thrombocytopenia was occurred 25 days after initiating therapy. Platelet and leukocyte count were 23,000/mm3, 2,850/mm3, respectively. Two week after discontinuation of antituberculous medication, platelet count was recovered. We report this case with a review of literature. (Intestinal Research 2006;4:64-68)


Intest Res : Intestinal Research
Close layer
TOP